Profile for European Patent Office Patent: 4215197
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 4215197
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,532,047 | May 16, 2039 | Rigel Pharms | REZLIDHIA | olutasidenib |
| 10,959,994 | May 16, 2039 | Rigel Pharms | REZLIDHIA | olutasidenib |
| 11,013,733 | May 16, 2039 | Rigel Pharms | REZLIDHIA | olutasidenib |
| 11,013,734 | May 16, 2039 | Rigel Pharms | REZLIDHIA | olutasidenib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
